Risk stratification and treatment effect of statins in secondary cardiovascular prevention in old age: Additive value of N-terminal pro-B-type natriuretic peptide
Agedcardiovascular diseasepro-brain natriuretic peptidehydroxymethylglutaryl-CoA reductase inhibitorsrisk factorssecondary prevention
